Risk Stratification in Severe Treatment-naive, Tricuspid Regurgitation

Risk Stratification in Patients With Severe Tricuspid Regurgitation: Insights From the TRicuspid Regurgitation rEgistry (TRuE)

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04173091

Acronym

TRuE

Enrollment

2000

Registered

2019-11-21

Start date

2013-01-01

Completion date

2023-12-30

Last updated

2020-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Tricuspid Regurgitation

Keywords

tricuspid regurgitation, tricuspid valve, percutaneous treatment, right ventricle

Brief summary

This registry is aimed to characterize patients with severe tricuspid regurgitation for the purpose of patient selection for interventional treatment and identify factors related to adverse outcomes.

Interventions

DIAGNOSTIC_TESTNo Intervention

No Intervention planed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Severe functional tricuspid regurgitation

Exclusion criteria

prior surgery or congenital heart diseases with involvement of the tricuspid valve

Design outcomes

Primary

Measure	Time frame	Description
All-cause mortality	1 year	Mortality due to all causes

Secondary

Measure	Time frame	Description
Cardiovascular mortality	1 year	Mortality due to cardiovascular causes
Number of hospitalizations	1 year	Number of hospitalizations due to right heart failure

Countries

Germany, Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026